NEVRO CORP's ticker is and the CUSIP is 64157FAA1. A total of 22 filers reported holding NEVRO CORP in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $18,188,000 | +18.9% | 17,970,000 | +9.1% | 1.72% | +15.2% |
| Q4 2018 | $15,298,000 | +2.3% | 16,470,000 | +9.6% | 1.49% | +7.7% |
| Q3 2018 | $14,959,000 | -40.2% | 15,031,000 | -34.7% | 1.38% | -36.8% |
| Q2 2018 | $25,003,000 | +4.6% | 23,031,000 | +10.4% | 2.19% | +11.4% |
| Q1 2018 | $23,902,000 | +6.3% | 20,853,000 | -3.4% | 1.97% | +2.0% |
| Q4 2017 | $22,486,000 | +34.5% | 21,582,000 | +38.3% | 1.93% | +18.4% |
| Q4 2016 | $16,717,000 | -50.6% | 15,605,000 | -40.0% | 1.63% | -50.6% |
| Q3 2016 | $33,833,000 | +42.7% | 26,000,000 | +15.6% | 3.30% | +34.9% |
| Q2 2016 | $23,709,000 | – | 22,500,000 | – | 2.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 27,600,000 | $33,560,000 | 1.29% |
| OAKTREE CAPITAL MANAGEMENT LP | 27,840,000 | $33,841,000 | 0.49% |
| Nicholas Investment Partners, LP | 5,530,000 | $6,692,000 | 0.47% |
| WOLVERINE ASSET MANAGEMENT LLC | 22,625,000 | $27,455,000 | 0.43% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 15,650,000 | $19,064,000 | 0.36% |
| CAMDEN ASSET MANAGEMENT L P /CA | 9,275,000 | $11,223,000 | 0.29% |
| LINDEN ADVISORS LP | 1,751,000 | $2,130,000 | 0.08% |
| LORD, ABBETT & CO. LLC | 14,387,000 | $17,480,000 | 0.05% |
| AVIVA PLC | 4,500,000 | $5,468,000 | 0.03% |
| Allianz Asset Management GmbH | 24,995,000 | $30,481,000 | 0.03% |